SAN JOSE, Calif., Aug. 14 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices forthe minimally invasive treatment of venous reflux disease, is enjoying ...

MINNEAPOLIS, Minnesota – Vascular Solutions, Inc. today announced that it is marketing a reprocessing service for the ClosureFAST radiofrequency ablation catheter in the United States. The ClosureFAST ...

Study Demonstrates Long-Term Durability of the ClosureFast™ Radiofrequency Ablation System for Treatment of Chronic Venous Insufficiency MANSFIELD, Mass.-- Covidien, a leading global provider of ...

September 26, 2006 -- The US Food and Drug Administration (FDA) has granted a clinical laboratory improvement amendment waiver for a portable lead test, thereby improving its availability and access, ...

Covidien (Mansfield, Massachusetts) reported the five-year results of its ClosureFast long-term European multi-center study in patients with chronic venous insufficiency (CVI). This study evaluates ...

Jamestown Regional Medical Center announces the addition of advanced vein care services at its outpatient specialty clinic, expanding access to minimally invasive treatment options for patients ...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast ® ...

DUBLIN - Feb. 10, 2015 - The ClosureFast(TM) endovenous radiofrequency ablation catheter from Medtronic plc (MDT) is safe and effective for the treatment of chronic venous insufficiency (CVI) over ...

Medical device major Medtronic plc MDT recently unveiled 12-month results from its VeClose study, validating the clinical durability of its VenaSeal closure system, at the European Venous Forum 2015 ...

Medtronic's Covidien business has agreed to pay $20 million to resolve kickback allegations, becoming the company's third announced federal legal resolution in three months. Medtronic, with ...

Covidien Announces Five-Year Results from the ClosureFast™ Long-Term European Multi-Center Study in Patients with Lower Limb Venous Disease Study Demonstrates Long-Term Durability of the ClosureFast™ ...